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Background. The NuRD/Mi2 chromatin complex is involved in histone modifications and contains a large number of subunits,
including the p66 protein. There are two mouse and human p66 paralogs, p66a and p66b. The functions of these genes are not
clear, in part because there are no mutants available, except in invertebrate model systems. Methodology. We made loss of
function mutants in the mouse p66a gene (mp66a, official name Gatad2a, MGI:2384585). We found that mp66a is essential for
development, as mutant embryos die around day 10 of embryogenesis. The gene is not required for normal blastocyst
development or for implantation. The phenotype of mutant embryos and the pattern of gene expression in mutants are
consistent with a role of mp66a in gene silencing. Conclusion. mp66a is an essential gene, required for early mouse
development. The lethal phenotype supports a role in execution of methylated DNA silencing.
Citation: Marino S, Nusse R (2007) Mutants in the Mouse NuRD/Mi2 Component P66a Are Embryonic Lethal. PLoS ONE 2(6): e519. doi:10.1371/
journal.pone.0000519
INTRODUCTION
Epigenetic changes in gene expression, such as occurring during
imprinting and X chromosome inactivation, can result from DNA
methylation and from chromatin remodeling. The latter includes
histone modifications such as deacetylation [1], acetylation [2],
and methylation [3]. Histone modifications and DNA methylation
are functionally linked to each other. Histone modifications are
catalyzed by a number of enzyme complexes, including the
NuRD/Mi2 complex [4]. DNA methyltransferases maintain
previously existing methylation (Dnmt1) and apply methyl groups
to previously non-methylated sites (Dnmt3a and Dnmt3b) [5,6].
Proteins that bind preferentially to methylated DNA have been
isolated. These include MeCP2, and MBDs 1, 2, and 4 [7–9]. Both
MBD2 [10] and MeCP2 [11] can recruit histone deacetylase
activity to methylated DNA, and this activity has been shown to
repress reporter genes in cell culture studies. MBD2 interacts with
the NuRD/Mi2 complex (Figure 1) and acts in the nucleus where
it is localized to both euchromatic and heterochromatic foci,
suggesting a role in facultative gene activity [10]. MeCP2 interacts
with the Sin3A complex and localizes primarily to pericentric
heterochromatin [12,13], indicating that it may contribute to
chromosome stability.
Another protein in the NuRD/Mi2 chromatin complex is
termed p66, cloned in Drosophila as a genetic modifier of Wingless
signaling [14]. Together with NuRD/Mi2 and MBD2, p66
comprises the MeCP1 complex [15,16] (Figure 1). There are two
human p66 paralogs, p66a and p66b [17], encoding proteins with
two conserved regions known as CR1 and CR2. The CR1 domain
has been shown to bind strongly to MBD3, a scaffolding protein of
the NuRD/Mi2 complex [17]. The 39 conserved region of p66a,
the Zn finger-containing CR2 domain, also interacts with MBD3,
while the CR2 region of p66b targets the complex to multiple
individual chromosomal loci in cell culture experiments [17–19].
To characterize the activity of p66 and assess its importance in
mouse development, we have made loss of function mutants in the
mouse p66a gene (mp66a, official name Gatad2a, MGI:2384585).
We report here that the gene is required for normal embryogenesis.
Figure 1. Composition of the NuRD/Mi2 chromatin complex, in-
cluding p66. Together with NuRD/Mi2 and MBD2 , p66 comprises the
MeCP1 complex. MBD2 and MeCP2 can recruit histone deacetylase
activity (HDAC) to methylated DNA See the text for references.
doi:10.1371/journal.pone.0000519.g001
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Cloning of mp66a, Genomic map, restriction
mapping, and knock-out strategy
By a combination of EST and cDNA mapping, we assembled
a 6.4 kb cDNA contig for mp66a. The transcript theoretically
encodes a protein of 630 amino acids with 87% identity and 93%
identity or similarity with human p66a (Figure 2). The protein
consists of two known conserved regions (CR): CR1 contains
a coiled-coil, a known protein-protein interaction domain, and
CR2 possesses a GATA type zinc finger region (Figure 2). To
design a construct for a targeted deletion, we isolated several BAC
clones from mouse strain 129/Sv and mapped the location of the
introns. The gene consists of 14 exons distributed over 15 kilo-
bases (Figure 3). We developed a strategy of homologous
recombination replacing the exons encoding CR1 and the two
flanking exons (exons 2–4) by a floxed pgk-neo cassette (Figure 3).
The resulting protein would consist of 86 amino acids from the
non-conserved region, followed by 34 amino acids not encoded by
the gene (due to frame-shifting) and a stop codon well before the
CR1 region (see Materials and Methods).
Homologous recombination and generation of
mp66a +/2 mice
We confirmed homologous recombination in 11% of the neo-
mycin-resistant R1 embryonic stem cells (Figure 4A, B). Northern
analysis of mutant ES cells showed that the mp66a RNA was
aberrant compared to wild type (Figure 4C), confirming a success-
ful deletion. Four independent ES cell clones were injected into
a total of 90 blastocysts, producing 33 pups altogether. Of these,
14 were chimeric according to coat color. Two males, one each
from clones 26 and 110, produced heterozygous offspring
(Figure 4D, E). Heterozygotes were viable, normal looking, and
fertile, producing offspring in normal Mendelian ratios when
crossed with wild type animals. Genotyping of 375 3-week-old
pups from heterozygote intercrosses revealed the presence of wild-
type and heterozygous animals at the expected 1:2 ratio (Table 1),
Figure 2. Sequence alignment of mouse and human p66a proteins. Identical residues are indicated by a *. The coiled-coil (CR1) and GATA type zinc
finger (CR2) regions are underlined. The arrows indicate the positions of the boundaries of Exons 2 and 4, which are eliminated after gene targeting.
The truncated protein consists of the region upstream from the first arrow, followed by 34 frameshifted amino acids.
doi:10.1371/journal.pone.0000519.g002
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animals, suggesting that the gene is essential for development.
Phenotypes of intercross embryos at day e8.5–e10.5
We examined intercross embryos at days e8.5 (embryogenesis 8.5)
through e12.5. Overall, we found a wide variety of defects.
Virtually every organ of candidate mutant embryos could be
affected, resulting in dramatically smaller embryos and advanced
stages of necrosis. We could not identify particular defects or
abnormalities that would suggest a specific step in embryogenesis
being dependent on mp66a. We present this analysis in tables 1
and 2, related to the timing of developmental arrest; and in figure 5
illustrating the degree of failure of development.
We found that by day e12.5, 61% of embryos were either wild-
type or heterozygous, while 39% were in such an advanced stage
of necrosis that they could not be examined or genotyped. For
embryonic days 8.5–10.5, we initially genotyped 82 whole animals
using a Southern blot protocol to account for all animals in a litter.
We obtained ratios close to normal Mendelian ratios: +/+, 0.96;
+/2, 1.92; 2/2,0.84 (Table 1). However, of the 6 animals not
genotyped in this group, 4 were less than half the size of siblings
and were probably null. This would change the ratios to
.96:1.92:1.04, indicating that all null embryos had implanted
successfully. When 114 e9.5 and e10.5 animals were visually
examined (Table 2), 24% displayed the arrested phenotype,
supporting this finding. Therefore, mp66a is essential for de-
velopment but not required for normal blastocyst development
and implantation.
An examination of 83 homozygous null e7.5–e10.5 embryos
from additional litters revealed a range of defects, delayed
development, and much smaller size than litter mates (Figure 5),
but with healthy placentas and often healthy tissue despite severe
delays.
A normal day 8.5 embryo has 8–12 somites, is in the process of
turning, has a paired heart primordial fusing anteriorly, and has
closed neural folds at somites 4–5 [20]. Of the 27 e8.5 null
embryos examined, 7 were in the egg cylinder stage as expected at
day 6 to 6.5. Two of these were lumpy and abnormally shaped and
two were in the early neural fold stage but were misshapen (not
shown). One of these had developed a single anterior neural fold,
but no somites. The remaining 18 embryos had a normal
appearance with somite numbers ranging from 3 to 9 (Figure 5).
Abnormalities in mp66a null embryos around day 9.5 included
malformed neural folds that were ruffled and not fused, failure of
closure of anterior neuropore, missing or excessively large blood
vessels in the yolk sac, turned but small underdeveloped embryos,
Figure 3. mp66a Knock-out and Genotyping Strategy. A: ploxPNT mp66a targeting vector. B: wild type mp66a genomic region. C: mutant mp66a
genomic region. D: mutant mp66a with pgkneo cassette removed. Gray rectangles are exons. Heavy black lines at top indicate location of
homologous arms. 5 and 6 are primers N-6 and 2-36 respectively. They were used to screen targeted clones by long range PCR for homologous
recombination. The expected band size was 2069 nt. Labeled restriction sites and external probes 9 and 11 were used to confirm correct targeting
and for some genotyping. 1–4 are primers used for PCR genotyping after recombination was shown to be correct by Southern blot genotyping. Short
Arm: Probe 11 Long Arm: Probe 9 NcoI WT=2335 bp Spe I, Sac I WT=8724 bp NcoI mutant=2799 bp Spe I, Sac I mutant=7633 bp
doi:10.1371/journal.pone.0000519.g003
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(Figure 5).
Differential gene expression in mp66a mutant
embryos
Given the evidence that p66 is part of a repressor complex, we
were interested in asking whether specific genes are affected by the
absence of mp66a in embryos. We carried out an Affymetrix
microarray analysis of 4 pairs of null vs. wild type day 8.5 siblings
that had achieved an equal level of development as judged during
dissection.
Over 45 genes were identified as being increased in the null
embryos of at least three but usually all four matched sibling pairs
(Table 3). Four of these genes, Psx2, Psx1(Placenta specific
homeobox 2 and 1), Cx31 (Connexin 31, specific to trophoblast
stem cells), and an unknown bHLH protein similar to Mash 2 are
active in the trophoblast lineage in the extraembryonic tissues of
the mouse. The remaining genes are either unknown, or not
confined to the extraembryonic lineages. Of particular interest are
two genes normally expressed in males only, but not found on the
Y chromosome, Amhr2 (anti-Mullerian hormone type 2 receptor)
and Ldh3 (lactate dehydrogenase 3, C chain, expressed normally
in the germinal epithelium of the testis). Despite the fact that three
of the null embryos were females, these genes were expressed at
heightened levels.
Because of the presumed role of p66 proteins in epigenetic gene
repression, we compared the mp66a null embryonic phenotype
with published mutants in other genes implicated in this process:
the DNA methyltransferases, Dnmt1, the maintenance methyl-
transferase, and Dnmt3a and Dnmt 3b, the de novo methyl-
transferases, and the histone methyltransferases G9a and
SUV39H [3]. G9a [21] is the histone methyltransferase thought
to be responsible for H3-K9 methylation in euchromatin and
therefore may be involved in developmental gene regulation.
SUV39H1 [22] is the name for both SUV39h homologs of this
Figure 4. Confirmation of correct targeting by molecular hybridization. A: Southern blot of SpeI, SacI digested clones hybridized with probe 9. The
long homologous arm is correctly integrated in clones numbered 26, 88,104 as indicated by the 7.6 kb fragment. B: Southern blot of Nco I digested
clones hybridized with probe 11. The short homologous arm is integrated correctly in clones numbered 329 and 88, as indicated by the 2.8 kb
fragment. C. Northern blot of RNA in +/2 and 2/2 ES cells. mp66a RNA is normal in the +/2 clone but aberrant in the 2/2 clone. GAPDH is the
loading control. D, E. Pups 1, 2, 3, 4, and 6 are heterozygous for the correctly integrated mutant alleles as shown for both the long arm (D) and the
short arm (E). These pups were the founders for two independently targeted lines, line 26 and line 110.
doi:10.1371/journal.pone.0000519.g004
Table 1. Intercross Genotypic Ratios.
......................................................................
Age genotype +/++ /22 /2 ?
newborns 123 (33%) 252 (67%) 0 0
e8.5 2 3 3 1
e9.5 11 18 6 2
e10.5 7 18 8 3
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heterochromatin and required for genome stability.
The mp66a null embryos were very similar to the Dnmt1 null,
Dnmt3a/3b double null, and the G9a null embryos. The Dnmt1
null embryo [23] is distinguishable from wild type embryos at day
e8.5 and by day e9.5 often has distorted neural tubes and no
somites. The most advanced null embryos had no more than
8 somites. The Dnmt3a/3b double null embryos were of smaller
size, had abnormal morphology at eE8.5 and e9.5, and died before
e11.5. They had no somites and did not turn [6]. The G9a null
embryos do not develop beyond the 5–6 somite stage, represen-
tative of approximately day 8.25, though they survive until day 9.5
when they begin to die. Like mp66a null embryos, some G9a null
embryos arrest as early as the egg cylinder and neural plate stage
[21]. The mp66a null phenotype was slightly less severe than each
of these – while the embryos died at about the same time, the
mp66a null embryos often had 20–30 somites. Nevertheless, the
consistency of these phenotypes implicates mp66a in the
epigenetic events that become important as differentiation
begins.
Figure 5. Mutant embryos. Embryonic Day 9.5 and 10.5 mp66a 2/2 Embryos. Mutant embryos, significantly smaller, are shown in comparison with
wild-type littermates. Abnormalities in mp66a null embryos around day 9.5 (A, B) include malformed and non-fused neural folds, failure of closure of
anterior neuropore, missing or excessively large blood vessels in the yolk sac, Day 10.5 embryos (C,D) are disintegrating due to multiple defects.
doi:10.1371/journal.pone.0000519.g005
Table 2. Intercross phenotypic ratios.
......................................................................
Age Total embryos normal arrested Not evaluated
e8.5 40 40 (100%) - -
e9.5 65 51 (78%) 12 (19%) 2 (3%)
e10.5 49 34 (69%) 15 (31%) -
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The NuRD/Mi2 complex, which includes p66 is found in all fetal
and adult tissues and its components are expressed throughout
early embryonic development from at least the 8–16 cell stage
onward [24]. Its nucleosomal remodeling ability is the highest of
the SWI2/SNF2 type ATPases [25] and it is the most active
HDAC activity found in Xenopus and mammalian cells. By making
mice mutant for mp66a, we show that the gene is essential for
normal development.
The lethal phenotype is consistent with a role in
execution of methylated DNA silencing
The mp66a2/2 mutation results in an embryonic lethal pheno-
type at around day e9.5. Because methylated DNA binding
proteins or activities are capable of repressing reporter genes by
recruiting histone deacetylase activity, the loss of HDAC due to
loss of mp66a should result in a DNA methyltransferase knockout
phenotype. The maintenance methyltransferase (Dnmt1)2/2
embryo dies by the eight somite stage, around day e8.5), while
the de novo Dnmt3a/3b methyltransferase double null embryo
dies before e11.5, with a variety of developmental abnormalities
[5,6]. This is consistent with the fact that methylation and
developmental gene silencing begins in earnest when the embryo
implants and gastrulation begins. The death of the mp66a2/2
embryo at e9.5 with variable developmental defects supports
therefore a role for mp66a in gene silencing.
The mp66a null phenotype appears to be less severe than the
knock-out phenotypes of two individual NuRD/Mi2 components.
The MBD3 null embryo is less developed than Dnmt2/2 embryo
and the HDAC1null embryo dies prior to e9.5 with a cell pro-
liferation defect [26,27]. Moreover, MBD3-deficient embryonic
stem cells, while able to initiate differentiation in embryoid bodies,
fail to commit to developmental lineages [28], whereas we found
that mp66a homozygous mutant ES cells differentiate normally
(data not shown). These differences may be the result of non-
MeCP1 functions of the NuRD/Mi2 complex. This may not be
unexpected, as mammalian p66a has only been associated with
NuRD/Mi2 in the MeCP1 context, yet MeCP1 contains only
about 10% of the NuRD in the cell [16].
On the other hand, we found that the mp66a phenotype is also
not as severe as that due to loss of all methylation. mp66a2/2
embryonic stem cells were capable of differentiating into embryoid
bodies at normal rates (data not shown), while Dnmt1 homozygous
mutant ES cells are reported to undergo more limited differen-
tiation at slower rates [23]. This suggests that if the phenotype is
a result of the elimination of MeCP1activity, then MeCP1 prob-
ably mediates only a subset of the methylation-dependent
repression. This might be expected because it is known that the
MeCP2 and the Sin3A HDAC complex are active in the
pericentromeric heterochromatin [9,29]. Alternatively, this result
could mean that loss of mp66a only partially disables the MeCP1
function.
If DNA methylation were dependent upon H3-K9 methylation,
and if mp66a were required for H3-K9 deacetylation, one would
expect to see loss of DNA methylation in mp66a2/2 ES cells,
even in a hypomethylated state. We used probe for minor satellite
methylation and an IAP probe to assess methylation of dispersed
repetitive elements. DNA methylation at all these loci was normal
in the ES cell cultures (data not shown).
Given the fact that methylated DNA binding activities and
proteins have been shown to repress reporter genes through
histone deacetylase activity, it has been puzzling that the MeCP2
and MBD2 knockouts have given viable, mild phenotypes [26,30].
Adding to the mystery is the fact that until now, only one
endogenous gene has been shown to be affected by a methylated
DNA binding protein or activity, and in this case the gene was
silenced by the absence of the binding protein, MBD2 [31], the
reverse effect.
MATERIALS AND METHODS
Cloning and genomic structure
We used the 39 UTR sequence of an existing mp66a clone to
identify additional mp66a clones in the NCBI mouse EST
database, of which only two extended beyond the UTR
(AI507147; AI429910). We sequenced these and assembled
a sequence (Figure 2) that extended 61 amino acids N terminal
of the published Xenopus p66a start site [32]. Incomplete genomic
sequence in the NCBI database indicated that there was another
exon 37 kb upstream that included the probable start site with an
imperfect Kozak sequence, but there were gaps in the intervening
cDNA sequence. This position, 141 amino acids N terminal of the
xp66a start site has now been established as the hp66a start site
[17]. Recent mouse ESTs (BY282871; CA317502) place the
orthologous start site at 139 amino acids N terminal of the mp66a
start site. We will assume this is the mouse start site as the human
and mouse genes are almost identical in all other respects.
We probed a BAC library (CITB Mouse BAC Clones, Research
Genetics, Cat. No. 96022) derived from mouse strain 129/Sv and
obtained 4 positive clones for mp66a (95E12; 412G8; 504L10;
604M1). Except for the 37 kb intron, we mapped the genomic
structure using long-range PCR with primers made to the cDNA
at regular intervals, and sequenced the amplimers into exon/
intron boundaries when introns were detected. We identified
critical sites for cloning and verified their presence in the 129/Sv
Table 3. Genes differentially expressed in mp66a mutant
embryos.
......................................................................
A. B. C. D.
3.6 1425035 DNMT3l DNA methyl-transferase 3-like
3.4 * 1432018 Mash 2 Achaete-Scute homolog-2
3.2 1433465 Unknown EST
3.2 *X 1449540 Psx 2 Placenta specific homeobox 2
2.9 1457021 Amhr2 Anti-Mullerian hormone receptor
2.8 1417945 Pou5f1 unknown transcription factor
2.7 1416490 Tmed6 possible transmembrane protein
2.7 1415846 Ldh3 lactate dehydrogenase 3, C chain
2.5 X 1419229 E hox repeat ES cell derived homeobox gene
2.4 *X 1419018 Psx 1 Placenta specific homeobox 1
2.2 X 1444038 unknown EST
2.1 1417426 Sgc, Prg1 Proteoglycan 1 granules
2.1 * 1416715 Cx31, Gjb3 Connexin 31
2.0 1422943 Hspb1 Heat shock protein 1
2.0 1416023 Fabp3 Fatty acid binding protein 3
2.0 X 1417216 Pim 2 proviral integration site 2
A. Average differential expression of genes, based on four comparison numbers
for the sibling pairs
B. Affymetrix code number for the sequence
C. Gene symbol
D. Gene description
*- expressed in extra-embryonic tissues
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PLoS ONE | www.plosone.org 6 June 2007 | Issue 6 | e519genomic DNA we was using for the construct. For the long-range
PCR we used the level 2 protocol of the Expand
TM Long
Template PCR System (Boehringer Mannheim) but scaled down
to a 25 mL reaction volume.
Gene targeting, ES cell culture, and genotyping
We made the targeting construct by cutting a 1.4 kb short
homologous arm and a 6.3 kb long homologous arm from the
129/Sv BAC clone 95E12, then used a shuttle vector to place
these arms into the targeting vector, ploxPNT. The targeting
vector was designed to replace exons 2–4 of mp66a with a floxed
pgkneo cassette. The homologous arms for the targeting construct
were cut from BAC 95E12, placed into Bluescript SK-, and finally
into the targeting vector ploxPNT (Figure 3) [33]. A portion of
each BAC digest was analyzed by Southern blot for identification
of the correct band. The HpaII/PstI 1.4 kb short arm fragment
was placed into PstI/ClaI site of BS SK- modified by the removal
of the Xho1 site by SalI/XhoI digestion and religation. The
BamHI/KpnI fragment was then removed and placed into the
BamHI/KpnI site of ploxPNT. The EcoRI/DraI 6.3 kb long arm
fragment was placed into the EcoRI/SmaI site of BS SK-. The
XhoI/NotI fragment was then removed and placed into the
XhoI/NotI site of ploxPNT. Internal probes and PCR assays for
the short and long arms utilized the following primers: short arm:
2-24 (59-gcccaccatgccactcttctt-39), 2-25 (59-gtcagatgcacaggtccacaac-
39); long arm: 2-14 (59-cgaggtgggcagcaggtgtct-39), 2-M2 (59-gggga-
cattggcgacacggataag-39). All junctions of the completed targeting
construct were sequenced to confirm correct construction.
Gene targeting was performed on passage #15 R1 ES cells
purchased from the Stanford Transgenic Research Facility. This
line was developed by the Andras Nagy lab (http://www.mshri.on.
ca/nagy/) in 1991 from 129/Svx129/SV-CP stock and has agouti
coat color in the F1 generation. ES cells were grown in gelatinized
dishes on neomycin resistant c irradiated mouse embryonic
fibroblasts in ES complete medium consisting of DME-H21
(UCSF#AA400) supplemented with 20% fetal bovine serum
(Hyclone, ES tested lot AKH12368), 0.1 mM non-essential amino
acids (Gibco#11140-0500), 16 penicillin-streptomycin (Gibco
#15140-122), 1 mM sodium pyruvate (Gibco#11360-070),
100 mM b-Mercaptoethanol (Sigma # M-7522), and 2000 U/
mL murine LIF (ESGRO
TM, Chemicon ESG1106) (Stanford
Transgenic Facility protocol) [34]. The targeting vector was
linearized at the Not 1 site and the ES cells were transfected by
electroporation. After 24 hours 0.5 mg/mL G418 (Cellgro MT61-
234-RF) and 2 mM gancyclovir (Syntex) were added for positive
and negative selection. After 7–10 days positive colonies were
picked and grown for stocks and analysis. Homologous recombi-
nants were identified first by detection of a 2069 bp band by long
range PCR (above) over the short (59) arm with primers 2-36 (59-
acctggaattgaagctgtctgat-39) and N-6 (59-cgccttcttgacgagttcttctg-39),
and then they were confirmed by Southern blot analysis of both
arms. For the short arm, ES cell DNA was digested with NcoI and
the blots probed with probe 11, a 550 bp fragment amplified from
BAC 95E12 with primers 2-39 (59-tggaaggcacagttaaagggtcac-39)
and 2-40 (59-ccccgaggtcaggtttcaaggtg-39). The wild type allele gave
a 2.34 kb band while homologously recombined alleles gave
a 2.80 kb band. For the long arm, DNA was digested with SpeI
and SacI, then probed with probe 9, a 535 bp fragment amplified
from BAC 95E12 with primers 2-41 (59-ggtagcatcccatagtcccaggtt-
39) and 2-42 (59-atgtggctgattgggggatgg-39). The wild type gene
gave an 8.72 kb band, while homologous recombinants gave
a 7.63 kb band (Figure 4).
After southern blot confirmation of homologous recombination
in cell and animal lines, a PCR genotyping protocol was developed
utilizing primers 2-30 (59-agacttgagtgtgcagggttgagg-39), 2-32 (59-
gccgggtattcgagtggaggaggt-39), 2-Q (59-aatcacatcaggcgagggaggtct-
39), and N-5 (59-ttggctacccgtgatattgctgaa-39). N-5 is found only in
the pgk-neo cassette while 2-Q is only in the targeted region;
primers 2-30 and 2-32 flank the targeted region. A 25 mL PCR
reaction consisting of 0.4 mM primer 2-30, 0.2 mM each
remaining primer, 0.8 mM dNTPs, 1.5 U Taq DNA polymerase
(Promega, Cat.M2861), 16Mg-free supplied PCR buffer, 4.5 mM
MgCl2,1mL template, and H2O to volume, was cycled as follows:
1 cycle: 94uC, 2 min; 30 cycles: 94uC, 1 min, 61uC, 1 min, 72uC,
1 min; 1 cycle: 72uC, 5 min. Primers 2-30 and N-5 gave an 835
mutant band; primers 2-30 and 2-Q gave a 632 bp wild type band;
primers 2-30 and 2-32 gave a 322 bp D mutant band and
a 2000 bp wild type band.
Generation and breeding of mice
Correctly targeted ES cells were injected into C57BL/6
blastyocysts [20] at the Stanford Transgenic Research Facility.
Chimeric pups were identified by mixed black and agouti coat
color and were crossed with C57BL/6 females at 6 weeks of age.
The chimeras with the highest percentage of 129/Sv agouti color
all developed teratocarcinomas (3) or were sterile (3). Three more
were non-transmitters, and three were female. Agouti pup tail
DNA was genotyped initially by Southern blot (above) but once
the mutation was confirmed in both lines 110 and 26, a PCR
protocol was used. The phenotype was analyzed for the most part
on a mixed C57BL/6X129/Sv background in which there was no
more than 75% of one of the strains. However, we did obtain a few
100% 129/Sv pups for both lines by crossing the proven chimeras
with 129/Sv females.
We wanted to eliminate possible confounding effects of the pgk
promoter on neighboring genes. To do this, we crossed the
heterozygous mp66a females to a CMVCre recombinase male to
produce offspring mosaic for the pgkneo deletion. These were then
crossed to wild type animals to obtain pure Dpgk mp66a lines for
both lines 26 and 110 (Figure 4D). These results were on animals
with a mixed 129/Sv X C57Bl/6 background. It was possible that
variability would be reduced on an isogenic background. We crossed
the chimeras with 129/Sv females and obtained 100% 129/Sv
heterozygotes.Althoughfertilitywaspoorintheselines,wewereable
to confirm the phenotype in a few (6) embryos on the 100%
background. In this case the variability ranged from abnormal
looking neural folds at e8.5 to embryos that did not turn at e9.5.
To remove the floxed pgk-neo cassette, we crossed heterozygous
mp66a females of both lines, 110 and 26, to a CMV-Cre male on
a C57BL/129/SV background. Offspring receiving the CMV-Cre
transgene were mosaic for the deletion so these were crossed again
to wild type to produce pure Dmp66a lines on a mixed background.
The Dmp66a110 and Dmp66a26 lines were then maintained in the
heterozygous condition on a mixed background as stock.
Microarray analysis
Because aberrant RNA is produced in the null animals, we could
genotype the embryonic RNA using RT-PCR. Individual RNA
from three litters was examined and genotyped for quality and
mp66a genotype. Extraembryonic membranes were included with
each embryo. Four sibling pairs were chosen from the three litters
for microarray analysis. An Affymetrix protocol was used so that
each embryo produced an individual set of expression data that
could be compared as desired, and all sample pairs were prepared
simultaneously. Sex was determined by examining the expression
data. Two pairs were entirely female while two other pairs were
mixed.Thedataforeachpairwasexaminedinparallelforeachgene
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the four pairs. There was one male each of null and wild type, so
thesewerecomparedtoeachotheralso.Thewildtypemaleandwild
type females were compared to confirm known male/female
differences and to include them in interpretation. In all cases
examined for known genes, the results were sex appropriate.
PolyA-RNA was then isolated using the spin column protocol of
the Oligotex mRNA midi kit (Qiagen). For microarray analysis,
the RNA was quantitated in a Beckman DU530 spectrophotom-
eter and labeled cDNA was made using the Cyscribe labeling kit.
The lab reference RNA, (1/4 four-week whole brain : 3/4 e 12.5
complete embryo), was labeled with Cy3 and the ES cell RNA was
labeled with Cy5. 0.25 M NaOH was added to degrade RNA
during a 15 minute 37uC incubation, then 0.7 M HEPES free
acid was added to neutralize. Final purification was carried out
with the CyScribe GFX Purification Kit. Absorbance at
550 nm(Cy3) and 650 nm (Cy5) was determined to quantitate
incorporation of label, so that equimolar amounts of Cy3 and Cy5
could be used for hybridization. Mouse microarrays were
purchased from the SFGF facility, and were stabilized, immobi-
lized, and pre-hybridized as follows. Slides were etched in one
corner to identify side of slide printed with the array, and then
rehydrated, array side down, over 45uC1 6SSC, then snap-dried
on a 100uC surface until the vapor disappeared, then UV cross-
linked at 65 mJoules. To prehybridize, arrays were incubated with
50% formamide, 36 SSC, 0.1%SDS, 0.1 mg/mL BSA for
45 minutes at 42uC, immersed in milliQ water to remove SDS,
and dried by centrifugation at 600 rpm for 2 minutes.
For hybridization, 40 pmol of reference and ES cell DNA were
mixed, 20 ug each of mouse Cot1 DNA, polyA RNA, and tRNA
were added, and the sample was concentrated to 28 mL in a foil
covered speed-vac. 6 mL2 0 6 SSC and 0.5 mL 20% SDS were
added, samples were denatured at 100uC for 2 minutes, and then
spun at 14,000 rpm in a microfuge for 15 minutes. The mixture
was then pipetted onto the microarray slide and covered.
Hybridization was carried out in a Gene Machines HybCham-
ber
TM humidified with 36SSC and submersed in a 65uC water
bath for 14–18 hours. The slides were then washed in foil covered
slide dishes as follows: 26SSC, 0.2% SDS at 55uC, 10 minutes,
removing cover slips when immersed; 16 SSC. 0.2% SDS at
55uC, 10 minutes; 0.16SSC, 0.2% SDS at RT, 10 minutes; 0.16
SSC at RT, 10 minutes; distilled water for 10 seconds followed
immediately by centrifugation drying as above. The slides were
then immediately scanned with a GenePix scanner with photo-
multiplier tube voltages in each channel adjusted to a ratio of
between 0.8–1.2. Images were then gridded and flagged using the
GenePix Pro 4.0 Software, then sent to the Stanford Microarray
Database.
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